Concepedia

Sridhar Vempati

SV

7

Publications

1.8K

Citations

7

H-Index

2006

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Ludwig-Maximilians-Universität München

Harvard Stem Cell Institute

Munich Leukemia Laboratory (Germany)

Harvard University

Sridhar Vempati is an author at Dana-Farber Cancer Institute specializing in tumor biology, chromatin, and medicine.

Top concepts

Publications per year

2006–2015

7

Publications

7

MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L

Kathrin M. Bernt, Nan Zhu, Amit Sinha et al. · Cancer Cell · 2011 · 883 citations · Full text

, , +9

H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias

Andrei V. Krivtsov, Zhaohui Feng, Madeleine E. Lemieux et al. · Cancer Cell · 2008 · 547 citations · Full text

, , +6

Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML

Carola Reindl, Ksenia Bagrintseva, Sridhar Vempati et al. · Blood · 2006 · 129 citations · Full text

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos et al. · Clinical Cancer Research · 2009 · 116 citations

Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL

Matthew C. Stubbs, Won-Il Kim, Megan Bariteau et al. · Clinical Cancer Research · 2015 · 81 citations · Full text

Rows per page

1–5 of 7